Références
BAKKEVOLD K.E., ARNESJO B., DAHL O., KAMBESTAD B. — Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater. Results of a controlled, prospective, randomized multicentre study.Eur. J. Cancer, 1995,29, 698.
BARISH M.A., YUCEL E.K., FERRUCCI J.T. — Magnetic resonance cholangiopancreatography.N. Engl. J. Med., 341, 258–263.
BARTON-BURKE M., — Gemcitabine: a pharmacologic and clinical overview.Cancer Nursing, 1999,22, 176–183.
BEDENNE L., VILLING A.L., CHAUFFERT B. — Lutte contre le cancer du pancréas exocrine: stagnation ou progrès? Le point de vue de la Fondation Française de Cancérologie Digestive (FFCD).Cancer/Radiother., 1997,1, 555–563.
BIRK D., SCHÖNBERG M.H., GANSAUGE F.,et al. — Carcinoma of the head of the pancreas arising from the uncinate process.Br. J. Surg., 1998,85, 498–501.
BURRIS III H.A., MOORE M.J., ANDERSEN J.,et al. — Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.J. Clin. Oncol., 1997,15, 2403–2413.
CAMERON J.L., CRIST D.W., SITZMANN J.V.,et al. — Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.Am. J. Surg., 1991,61, 120–125.
CRUCITTI F. DOGLIETTO G.B., FRONTERA D.,et al. — Integrated radiosurgical treatment of resectable pancreatic head carcinoma.Pancreas, 1998,16, 31–39.
DAVIDS P.H.P., GROEN A.K., RAUWS E. A.J.,et al. — Randomized trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction.Lancet Dec., 1992,19/26, 1488–1492.
DOUGLASS H.O. — Adjuvant therapy for pancreatic cancer.World J. Surg., 1995,19: 270–274.
GEER R.J., BRENNAN M.F. — Prognostic indicators for survival after resection of pancreatic adenocarcinoma.Am. J. Surg., 1993,165, 68–73.
HIRATA K., SATO T., MUKAIYA M.,et al. — Results of 1001 pancreatic resections for invasive ductal adenocarcinoma of the pancreas.Arch. Surg., 1997,132, 771–777.
JOHN T.G., GREIG J.D., CARTER D.C., GARDEN O.J. — Carcinoma of the pancreatic head and periampullary region. Tumor staging with laparoscopy and laparoscopic ultrasonography.Ann. Surg., 1995,221, 156–164.
JOHNSON C.D., SCHWALL G., FLECHTENMACHER J., TREDE M. — Resection for adenocarcinoma of the body and tail of the pancreas.Br. J. Surg., 1993,80, 1177–1179.
JUNG M. — Diagnostic précoce du cancer du pancréas. Mission impossible.Acta Endoscopica, 1999,29, 79–83.
KAMTHAN A., MORRIS J.C., DALTON J.,et al. — Combined modality therapy for stage II and stage III pancreatic carcinoma.J. Clin. Oncol., 1997,15, 2920–2927.
KAYAHARA M., NAGAKAWA T., OHTA T.,et al. — Analysis of paraaortic lymph node involvement in pancreatic carcinoma. A significant indication for surgery?American Cancer Society, 1999,85, 583–590.
KURTZ J.-E., TRILLET-LENOIR V., BUGAT, R.,et al. — Utilisation compassionnelle de la gemcitabine dans les cancers du pancréas localement avancés ou métastatiques: une étude multicentrique française.Bull Cancer, 1999,86 (2), 202–206.
LINK K.H., GANSAUGE F., GOERICH J.,et al. — Palliative and adjuvant regional chemotherapy in pancreatic cancer.Eur. J. Surg. Oncol., 1997,23, 409–414.
MORNEX F., CHAUFFERT B. — Chimioradiothérapie concomitante dans la stratégie thérapeutique des adénocarcinomes du pancréas exocrine et de l'estomac.Cancer/Radiother., 1998,2, 696–702.
NAKAO A., HARADA A., NONAMI T.,et al. — Lymph node metastasis in carcinoma of the body and tail of the pancreas.Br. J. Surg., 1997,84, 1090–1092.
NIEDERAU C., GRENDELL J.H. — Diagnosis of pancreatic carcinoma.Pancreas, 1992,7, 66–86.
RODER J.D., SDEIN H.J., SIEWERT J.R. — Carcinoma of the periampullary region. Who benefits from portal vein resection?Am. J. Surg., 1996,171, 170–174.
ROSEWICZ S., WIEDENMANN B. — Pancreatic carcinoma.Lancet, 1997,349, 485–489.
ROTHENBERG M.L., BURRIS III. H.A., ANDERSEN J.S.,et al. — Gemcitabine: effective palliative therapy for pancreas cancer patient failing 5-FU.Proc. Am. Soc. Clin. Oncol., 1995,14, 198.
SAEIAN K., REDDY K.R. — Diagnostic laparoscopy: an update.Endoscopy, 1999,31, 103–109.
SCHNALL S.F., MacDONALD J.S. — Chemotherapy of adenocarcinoma of the pancreas.Semin. Oncol., 1996,23, 220–228.
SPERTI C., PASQUALI C., PICCOLI A., PEDRAZZOLI S. — Survival after resection for ductal adenocarcinoma of the pancreas.Br. J. Surg., 1996,83, 625–631.
TADA M., OHASHI M., SHIRATORI Y.,et al. — Analysis of ki-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease.Gastroenterol., 1996,110, 227–231.
THOMAS P.R.M. — Radiotherapy for carcinoma of the pancreas.Semin. Oncol., 1996,23, 213–219.
TREDE M., SCHWALL G., SAEGER H.D. — Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality.Ann. Surg., 1990,211, 447–458.
TSUCHIYA R., NODA T., HARADA N.,et al. — Collective review of small carcinomas of the pancreas.Ann. Surg., 1986,203, 77–81.
TSUNODA T., YAMAMOTO Y., KIMOTO M.,et al. — Staging and treatment for patients with pancreatic cancer. How small is an early pancreatic cancer?J. Hep. Bil. Pancr. Surg., 1998,5, 128–132.
VON HOFF D.D., GOODWIN A.L., GARCIA L. — and the San Antonio Drug Development Team. Advances in the treatment of patients with pancreatic cancer: improvement in symptoms and survival time.Br. J. Cancer, 1998,78 (Suppl. 3), 9–13.
YANAGISAWA A., OHTAKE K., OHASHI K.,et al. — Frequent c-ki-ras oncogene activation in mucous cell hyperplasia of pancreas suffering from chronic inflammation.Cancer Res., 1993,53, 953–956.
Author information
Authors and Affiliations
About this article
Cite this article
Jung, M. Le traitement du cancer du pancréas n'est pas chirurgical. Acta Endosc 29 (Suppl 2), 359–361 (1999). https://doi.org/10.1007/BF03019316
Issue Date:
DOI: https://doi.org/10.1007/BF03019316